Equine Metabolic Syndrome: A Complex Disease Influenced by Multifactorial Genetic Factors

Equine metabolic syndrome (EMS) has become an important issue in modern veterinary medicine and is linked to the common, extremely painful, most-of-the-time performance-terminating hoof laminitis. The growing knowledge in the field of genetic background, inducing environmental factors, diagnosis, treatment and maintenance of affected equines led us to summarise the available information to be used not only for scientific purposes but for fieldwork. In horses, the clinical presentation of EMS includes: obesity or local fat deposition, bilateral lameness or hoof rings attributed to ongoing or previous (pasted) laminitis with the key feature of the occurrence of insulin dysregulation, disturbing the homeostasis within insulin, glucose and lipid metabolism. The management of EMS is based on dietary and fitness discipline; however, intensive research is ongoing in the field of regenerative medicine to develop modern and promising therapies.

[1]  E. Valle,et al.  Effect of sugar metabolite methylglyoxal on equine lamellar explants: An ex vivo model of laminitis , 2021, PloS one.

[2]  A. Pfeiffer,et al.  The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update , 2021, Diabetes, obesity & metabolism.

[3]  M. D. de Laat,et al.  Preliminary analysis of the FAM174A gene suggests it lacks a strong association with equine metabolic syndrome in ponies. , 2020, Domestic animal endocrinology.

[4]  Mandi J. Lopez,et al.  The Equine Hoof: Laminitis, Progenitor (Stem) Cells, and Therapy Development , 2019, Toxicologic pathology.

[5]  K. Marycz,et al.  Systemic Administration of Rejuvenated Adipose-Derived Mesenchymal Stem Cells Improves Liver Metabolism in Equine Metabolic Syndrome (EMS)- New Approach in Veterinary Regenerative Medicine , 2019, Stem Cell Reviews and Reports.

[6]  J. Keen,et al.  Adipose tissue dysfunction in obese horses with equine metabolic syndrome , 2019, Equine veterinary journal.

[7]  C. McGowan,et al.  ECEIM consensus statement on equine metabolic syndrome , 2019, Journal of veterinary internal medicine.

[8]  M. McCue,et al.  Evaluation of an HMGA2 variant for pleiotropic effects on height and metabolic traits in ponies , 2019, Journal of veterinary internal medicine.

[9]  C. Pollitt,et al.  Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies , 2018, Journal of veterinary internal medicine.

[10]  K. Marycz,et al.  Excessive Endoplasmic Reticulum Stress Correlates with Impaired Mitochondrial Dynamics, Mitophagy and Apoptosis, in Liver and Adipose Tissue, but Not in Muscles in EMS Horses , 2018, International journal of molecular sciences.

[11]  M. Mallicote,et al.  Genomewide association study reveals a risk locus for equine metabolic syndrome in the Arabian horse. , 2017, Journal of animal science.

[12]  J. McGree,et al.  Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. , 2016, American journal of physiology. Endocrinology and metabolism.

[13]  K. Marycz,et al.  Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy , 2016, Journal of cellular and molecular medicine.

[14]  Li Zhou,et al.  NS5ATP6 modulates intracellular triglyceride content through FGF21 and independently of SIRT1 and SREBP1. , 2016, Biochemical and biophysical research communications.

[15]  C. Drögemüller,et al.  A Non-Synonymous HMGA2 Variant Decreases Height in Shetland Ponies and Other Small Horses , 2015, PloS one.

[16]  M. McCue,et al.  Equine Metabolic Syndrome: A Complex Disease Influenced by Genetics and the Environment , 2015 .

[17]  Yang Li,et al.  Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome. , 2014, Drug discovery today.

[18]  L. Peelman,et al.  Expression of inflammation-related genes is associated with adipose tissue location in horses , 2013, BMC Veterinary Research.

[19]  C. Pollitt,et al.  A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis. , 2013, Veterinary journal.

[20]  L. J. McCutcheon,et al.  Distribution of insulin receptor and insulin-like growth factor-1 receptor in the digital laminae of mixed-breed ponies: an immunohistochemical study. , 2013, Equine veterinary journal.

[21]  R. Pepperkok,et al.  RNAi–Based Functional Profiling of Loci from Blood Lipid Genome-Wide Association Studies Identifies Genes with Cholesterol-Regulatory Function , 2013, PLoS genetics.

[22]  L. Katz,et al.  A review of recent advances and current hypotheses on the pathogenesis of acute laminitis. , 2012, Equine veterinary journal.

[23]  S. Eades,et al.  Insulin resistance in equine digital vessel rings: an in vitro model to study vascular dysfunction in equine laminitis. , 2011, Equine veterinary journal.

[24]  C. Pollitt,et al.  Glucose transport in the equine hoof. , 2011, Equine veterinary journal.

[25]  G. Reaven,et al.  The metabolic syndrome: time to get off the merry‐go‐round? , 2011, Journal of internal medicine.

[26]  D. Pfeiffer,et al.  Epidemiological study of pasture-associated laminitis and concurrent risk factors in the South of England , 2010, Veterinary Record.

[27]  V. Ganjam,et al.  Laminitis and the equine metabolic syndrome. , 2010, The Veterinary clinics of North America. Equine practice.

[28]  C. Pollitt,et al.  Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? , 2010, Equine veterinary journal. Supplement.

[29]  R. Geor,et al.  Equine metabolic syndrome. , 2010, Journal of veterinary internal medicine.

[30]  S. Pratt-Phillips,et al.  Assessment of resting insulin and leptin concentrations and their association with managerial and innate factors in horses. , 2010 .

[31]  C. Pollitt,et al.  Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. , 2010, Equine veterinary journal.

[32]  S. Bailey,et al.  Proliferative Effects of Insulin on Equine Lamellar Epithelial Cells Mediated By the IGF-1 Receptor , 2010 .

[33]  D. Pfeiffer,et al.  Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. , 2010, Equine veterinary journal.

[34]  L. J. McCutcheon,et al.  Effects of diet-induced weight gain on insulin sensitivity and plasma hormone and lipid concentrations in horses. , 2009, American journal of veterinary research.

[35]  C. McGowan,et al.  Correlation of Plasma Insulin Concentration with Laminitis Score in a Field Study of Equine Cushing's Disease and Equine Metabolic Syndrome , 2009 .

[36]  R. Geor,et al.  Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies. , 2009, Veterinary journal.

[37]  L. Douglass,et al.  Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. , 2009, Equine veterinary journal.

[38]  U. Broedl,et al.  Adipokines and Insulin Resistance , 2008, Molecular medicine.

[39]  C. Pollitt,et al.  Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. , 2007, Veterinary journal.

[40]  A. Klip,et al.  Small G proteins in insulin action: Rab and Rho families at the crossroads of signal transduction and GLUT4 vesicle traffic , 2007, Acta physiologica.

[41]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[42]  S. Rattigan,et al.  Obesity, Insulin Resistance, and Capillary Recruitment , 2007, Microcirculation.

[43]  C. Kearns,et al.  Adiponectin and leptin are related to fat mass in horses. , 2006, Veterinary journal.

[44]  A. Carpentier,et al.  The metabolic syndrome. , 2006, Pathologie-biologie.

[45]  S. Bailey,et al.  Countermeasures for pasture-associated laminitis in ponies and horses. , 2006, The Journal of nutrition.

[46]  K. Treiber,et al.  Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. , 2006, Journal of the American Veterinary Medical Association.

[47]  D. Keisler,et al.  Physical characteristics, blood hormone concentrations, and plasma lipid concentrations in obese horses with insulin resistance. , 2006, Journal of the American Veterinary Medical Association.

[48]  R. Boston,et al.  Insulin resistance and compensation in Thoroughbred weanlings adapted to high-glycemic meals. , 2005, Journal of animal science.

[49]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[50]  B. Doble,et al.  Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? , 2004, Biochemical Society transactions.

[51]  V. Ganjam,et al.  Endocrinopathic laminitis in the horse , 2004 .

[52]  R. Boston,et al.  Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. , 2003, Journal of animal science.

[53]  D. Thompson,et al.  The relationship between body condition, leptin, and reproductive and hormonal characteristics of mares during the seasonal anovulatory period. , 2002, Journal of animal science.

[54]  Philip Johnson.  The equine metabolic syndrome peripheral Cushing's syndrome. , 2002, The Veterinary clinics of North America. Equine practice.

[55]  N. White.  Equine laminitis , 1990, In Practice.

[56]  E. Tadros,et al.  Insulin dysregulation. , 2014, Equine veterinary journal.

[57]  R. Reeves.  Nuclear functions of the HMG proteins. , 2010, Biochimica et biophysica acta.

[58]  S. Bailey,et al.  Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. , 2008, American journal of veterinary research.